Loading company…
Metis Technologies develops AI-enabled nano-materials for targeted drug delivery.
Founded in 2020 and based in Beijing, Metis Technologies develops the AiLNP platform, which uses AI to optimize lipid nanoparticle delivery for biopharmaceutical applications, including oncology and regenerative medicine. It works with pharmaceutical companies and research institutions. In August 2025, the company raised CNY 40 million in Series D funding co-led by Beijing Medical and Health and Beishang Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in